Credit Suisse Downgrades PDL BioPharma (PDLI) to Underperform
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 5
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 5
Join SI Premium – FREE
Credit Suisse downgraded PDL BioPharma (NASDAQ: PDLI) from Neutral to Underperform.
For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.
Shares of PDL BioPharma closed at $7.42 yesterday.
For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.
Shares of PDL BioPharma closed at $7.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Downgrades Sonic Auto (SAH) to Neutral
- Cantor Fitzgerald Downgrades AtaiBeckley Inc (ATAI) to Neutral
- Needham Downgrades AtaiBeckley Inc (ATAI) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
